Healthcare provider profile · identity verified

Mehmet Karaca, MD

Internal Medicine · VERO BEACH, FL · NPI 1336819705

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	526	197
Amlodipine Besylate	Amlodipine Besylate	480	185
Rosuvastatin Calcium	Rosuvastatin Calcium	455	181
Levothyroxine Sodium	Levothyroxine Sodium	418	143
Lisinopril	Lisinopril	351	125
Losartan Potassium	Losartan Potassium	296	105
Omeprazole	Omeprazole	265	101
Metoprolol Succinate	Metoprolol Succinate	211	82
Hydrochlorothiazide	Hydrochlorothiazide	205	77
Metformin Hcl	Metformin Hcl	200	77
Alprazolam	Alprazolam	184	64
Simvastatin	Simvastatin	172	59
Pravastatin Sodium	Pravastatin Sodium	158	53
Pantoprazole Sodium	Pantoprazole Sodium	154	59
Tamsulosin Hcl	Tamsulosin Hcl	138	60
Allopurinol	Allopurinol	137	47
Zolpidem Tartrate	Zolpidem Tartrate	137	54
Metoprolol Tartrate	Metoprolol Tartrate	122	38
Gabapentin	Gabapentin	115	46
Sertraline Hcl	Sertraline Hcl	113	40
Trazodone Hcl	Trazodone Hcl	112	45
Furosemide	Furosemide	96	43
Montelukast Sodium	Montelukast Sodium	88	35
Ezetimibe	Ezetimibe	87	35
Ozempic	Semaglutide	87	20
Eliquis	Apixaban	86	31
Fluticasone Propionate	Fluticasone Propionate	86	40
Meloxicam	Meloxicam	81	35
Clopidogrel	Clopidogrel Bisulfate	70	28
Jardiance	Empagliflozin	70	20
Metformin Hcl Er	Metformin Hcl	69	27
Citalopram Hbr	Citalopram Hydrobromide	68	25
Valsartan	Valsartan	68	30
Alendronate Sodium	Alendronate Sodium	66	27
Escitalopram Oxalate	Escitalopram Oxalate	66	31
Potassium Chloride	Potassium Chloride	66	28
Duloxetine Hcl	Duloxetine Hcl	65	25
Albuterol Sulfate Hfa	Albuterol Sulfate	64	29
Glimepiride	Glimepiride	64	24
Lorazepam	Lorazepam	60	22
Atenolol	Atenolol	58	20
Pioglitazone Hcl	Pioglitazone Hcl	56	21
Fluoxetine Hcl	Fluoxetine Hcl	55	21
Carvedilol	Carvedilol	53	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	23
Celecoxib	Celecoxib	48	14
Fenofibrate	Fenofibrate Nanocrystallized	47	17
Finasteride	Finasteride	46	20
Prednisone	Prednisone	44	24
Paroxetine Hcl	Paroxetine Hcl	43	18
Famotidine	Famotidine	40	17
Donepezil Hcl	Donepezil Hcl	38	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	15
Pregabalin	Pregabalin	37	12
Tramadol Hcl	Tramadol Hcl	37	14
Diazepam	Diazepam	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	11
Olmesartan Medoxomil	Olmesartan Medoxomil	34	15
Fenofibrate	Fenofibrate	32	11
Temazepam	Temazepam	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	13
Venlafaxine Hcl Er	Venlafaxine Hcl	31	14
Azithromycin	Azithromycin	30	28
Bupropion Xl	Bupropion Hcl	30	17
Farxiga	Dapagliflozin Propanediol	30	suppressed
Clonazepam	Clonazepam	28	suppressed
Fluconazole	Fluconazole	28	16
Ipratropium Bromide	Ipratropium Bromide	28	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	27	11
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Sildenafil Citrate	Sildenafil Citrate	26	suppressed
Synthroid	Levothyroxine Sodium	26	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Glipizide	Glipizide	25	suppressed
Spironolactone	Spironolactone	25	11
Estradiol	Estradiol	24	13
Januvia	Sitagliptin Phosphate	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Buspirone Hcl	Buspirone Hcl	20	12
Ibuprofen	Ibuprofen	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Methylprednisolone	Methylprednisolone	20	20
Nitroglycerin	Nitroglycerin	19	13
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Baclofen	Baclofen	17	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Desloratadine	Desloratadine	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	16	16
Meclizine Hcl	Meclizine Hcl	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Prempro	Estrogen,con/M-Progest Acet	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Cephalexin	Cephalexin	14	14
Colchicine	Colchicine	14	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nadolol	Nadolol	13	suppressed
Ramipril	Ramipril	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error